1. Home
  2. CRBP vs LGO Comparison

CRBP vs LGO Comparison

Compare CRBP & LGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRBP
  • LGO
  • Stock Information
  • Founded
  • CRBP 2009
  • LGO 1988
  • Country
  • CRBP United States
  • LGO Canada
  • Employees
  • CRBP N/A
  • LGO N/A
  • Industry
  • CRBP Biotechnology: Pharmaceutical Preparations
  • LGO
  • Sector
  • CRBP Health Care
  • LGO
  • Exchange
  • CRBP Nasdaq
  • LGO Nasdaq
  • Market Cap
  • CRBP 114.8M
  • LGO 110.9M
  • IPO Year
  • CRBP N/A
  • LGO 2007
  • Fundamental
  • Price
  • CRBP $16.22
  • LGO $2.56
  • Analyst Decision
  • CRBP Strong Buy
  • LGO Strong Buy
  • Analyst Count
  • CRBP 8
  • LGO 1
  • Target Price
  • CRBP $50.57
  • LGO $3.70
  • AVG Volume (30 Days)
  • CRBP 221.8K
  • LGO 786.8K
  • Earning Date
  • CRBP 11-06-2025
  • LGO 11-11-2025
  • Dividend Yield
  • CRBP N/A
  • LGO N/A
  • EPS Growth
  • CRBP N/A
  • LGO N/A
  • EPS
  • CRBP N/A
  • LGO N/A
  • Revenue
  • CRBP N/A
  • LGO $108,526,000.00
  • Revenue This Year
  • CRBP N/A
  • LGO N/A
  • Revenue Next Year
  • CRBP $220.00
  • LGO $54.96
  • P/E Ratio
  • CRBP N/A
  • LGO N/A
  • Revenue Growth
  • CRBP N/A
  • LGO N/A
  • 52 Week Low
  • CRBP $4.64
  • LGO $1.12
  • 52 Week High
  • CRBP $20.77
  • LGO $2.84
  • Technical
  • Relative Strength Index (RSI)
  • CRBP 76.29
  • LGO 78.46
  • Support Level
  • CRBP $15.00
  • LGO $1.75
  • Resistance Level
  • CRBP $16.97
  • LGO $2.70
  • Average True Range (ATR)
  • CRBP 1.01
  • LGO 0.21
  • MACD
  • CRBP 0.28
  • LGO 0.08
  • Stochastic Oscillator
  • CRBP 88.62
  • LGO 92.31

About CRBP Corbus Pharmaceuticals Holdings Inc.

Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

About LGO Largo Inc.

Largo Inc is committed to the production and supply of high-quality vanadium products. The company is also focused on the advancement of renewable energy storage solutions through Largo Clean Energy and its vanadium redox flow battery technology. The Company is engaged in the mining, exploration, and development of mineral properties, predominantly in Brazil, through which it produces and supplies vanadium products VPURE Flake, VPURE+ Flake, and VPURE+ Powder. The company has operating segments: sales & trading, mine properties, which generates key revenue, corporate, exploration and evaluation properties, Clean Energy, and Largo Physical Vanadium.

Share on Social Networks: